These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 15541412

  • 1. Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.
    Amaral E, Perdigão A, Souza MH, Mauck C, Waller D, Zaneveld L, Faúndes A.
    Contraception; 2004 Dec; 70(6):492-7. PubMed ID: 15541412
    [Abstract] [Full Text] [Related]

  • 2. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.
    Amaral E, Perdigao A, Souza MH, Mauck C, Waller D, Zaneveld L, Faundes A.
    Contraception; 2006 May; 73(5):542-7. PubMed ID: 16627043
    [Abstract] [Full Text] [Related]

  • 3. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
    Mauck CK, Baker JM, Barr SP, Johanson WM, Archer DF.
    Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
    [Abstract] [Full Text] [Related]

  • 4. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
    Mauck CK, Baker JM, Barr SP, Abercrombie TJ, Archer DF.
    Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
    [Abstract] [Full Text] [Related]

  • 5. Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.
    Amaral E, Faúndes A, Zaneveld L, Waller D, Garg S.
    Contraception; 1999 Dec; 60(6):361-6. PubMed ID: 10715372
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a randomized trial.
    Raymond EG, Chen PL, Luoto J, Spermicide Trial Group.
    Obstet Gynecol; 2004 Mar; 103(3):430-9. PubMed ID: 14990402
    [Abstract] [Full Text] [Related]

  • 9. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.
    Barnhart KT, Rosenberg MJ, MacKay HT, Blithe DL, Higgins J, Walsh T, Wan L, Thomas M, Creinin MD, Westhoff C, Schlaff W, Archer DF, Ayers C, Kaunitz A, Das S, Moench TR.
    Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603
    [Abstract] [Full Text] [Related]

  • 10. A phase I comparative postcoital testing study of three concentrations of C31G.
    Mauck CK, Creinin MD, Barnhart KT, Ballagh SA, Archer DF, Callahan MM, Schmitz SW, Bax R.
    Contraception; 2004 Sep; 70(3):227-31. PubMed ID: 15325892
    [Abstract] [Full Text] [Related]

  • 11. Lea's Shield: a phase I postcoital study of a new contraceptive barrier device.
    Archer DF, Mauck CK, Viniegra-Sibal A, Anderson FD.
    Contraception; 1995 Sep; 52(3):167-73. PubMed ID: 7587188
    [Abstract] [Full Text] [Related]

  • 12. GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion.
    D'Cruz OJ, Yiv SH, Uckun FM.
    AAPS PharmSciTech; 2001 Apr 09; 2(2):E5. PubMed ID: 14727880
    [Abstract] [Full Text] [Related]

  • 13. Vaginal contraception with gossypol: a clinical study.
    Ratsula K, Haukkamaa M, Wichmann K, Luukkainen T.
    Contraception; 1983 Jun 09; 27(6):571-6. PubMed ID: 6684533
    [Abstract] [Full Text] [Related]

  • 14. A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.
    Simoes JA, Bahamondes LG, Camargo RP, Alves VM, Zaneveld LJ, Waller DP, Schwartz J, Callahan MM, Mauck CK.
    Br J Clin Pharmacol; 2006 Feb 09; 61(2):211-7. PubMed ID: 16433875
    [Abstract] [Full Text] [Related]

  • 15. Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.
    Keller MJ, Carpenter CA, Lo Y, Einstein MH, Liu C, Fredricks DN, Herold BC.
    PLoS One; 2012 Feb 09; 7(10):e46901. PubMed ID: 23056520
    [Abstract] [Full Text] [Related]

  • 16. Vaginal contraceptive activity of a chelated vanadocene.
    D'Cruz OJ, Uckun FM.
    Contraception; 2005 Aug 09; 72(2):146-56. PubMed ID: 16022855
    [Abstract] [Full Text] [Related]

  • 17. In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse.
    Barnhart KT, Pretorius ES, Timbers K, Shera D, Shabbout M, Malamud D.
    Contraception; 2004 Dec 09; 70(6):498-505. PubMed ID: 15541413
    [Abstract] [Full Text] [Related]

  • 18. An overview of properties of Amphora (Acidform) contraceptive vaginal gel.
    Nelson AL.
    Expert Opin Drug Saf; 2018 Sep 09; 17(9):935-943. PubMed ID: 30136907
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.